INTRODUCTION
The onset of type 2 diabetes (T2D) leads in turn to the development of its long-term consequences: macrovascular complications (including atherosclerosis and amputations) and microvascular complications (including retinopathy, nephropathy and neuropathy). Insulin resistance is typically present throughout the progression from prediabetes to the later stages of overt T2D. Cross-sectional and prospective studies have described white blood cell count, elevated circulating levels of acute-phase proteins (such as C-reactive protein (CRP), haptoglobin, fibrinogen, plasminogen activator inhibitor and serum amyloid A) and sialic acid, as well as cytokines and chemokines in patients with T2D The immune response to various physiological challenges is characterized by increased neutrophil and decreased lymphocyte counts, and the neutrophil-to-lymphocyte ratio (NLR) was defined as a novel potential marker to determine inflammation in many kinds of chronic inflammatory disease including diabetes [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . The count of white blood cell (WBC) is a basic but cheap, readily available, and sensitive indicator of the inflammatory status. WBCs are positively associated with inflammation, particularly in cardiovascular diseases. An increase in the number of neutrophils is associated with thrombus formation and ischemic injury 17 .
The objective of this study was to evaluate the role of NLR as routine parameter in whole blood tests in T2DM patients, comparing with the other well-known inflammatory markers as CRP and fibrinogen. It also investigates usefulness of the NLR to prediction of complications in T2DM.
MATERIAL AND METHODS
The protocol was approved by the Local ethics Committee and was conducted in accordance with the Declaration of Helsinki. All participants were informed about the survey and voluntarily signed and dated the consent form. The medical histories and physical examination of all participants were obtained. 19 . Presence of HT, nephropathy, retinopathy (RP), neuropathy (NP) and history about coronary heart disease (CHD), cerebrovascular event (CVE), diabetic foot (DF) were reported.
Blood samples were obtained before drug use in the morning. Samples were collected in EDTAcontaining tubes and anticoagulant-free tubes after an overnight fast. After immediate centrifugation at 3000 g for 10 minute, at 4 °C, plasma and serum samples were separated. Routine parameters were studied on the same day.
Complete blood count parameters were obtained with automatic hematology analyzer (Abbott Laboratories, Diagnostics Division, Germany). Serum CRP levels were measured by nephelometry (Siemens-Dimention, Germany). The other rutin parameters were analyzed according to classic methods using analyzers (Roche Cobas İntegra 400, Roche Diagnostics Ltd. Germany). Insulin concentrations were measured by electrochemiluminescence immunoassay (ECLIA) method on Roche-Hitachi E170 (Roche/Hitachi MODULAR Analytics Combination Systems, Roche Diagnostics, USA). HbA1c determination was based on HPLC (Variant Turbo II, Bio-Rad Laboratories, Inc. USA).
HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) was calculated according to the formula: fasting insulin (microU/L) x fasting glucose (nmol/L)/22.5.
Statistical analysis
SPSS (Statistical Package for Social Sciences) for Windows 21.0 package program was used for statistical evaluations. The relationship between the categorical variables of the groups was examined by chi-square test. Descriptive statistics were obtained and data were tested for normality using the Kolmogorov-Smirnov test for Gaussian distribution. For comparison of parameters with normal distribution parametric tests and comparison of parameters with abnormal distribution non-parametric tests were used. For this purpose, One-Way ANOVA, unpaired student-t, Kruskal-Wallis and Mann-Whitney U tests were used. Relationships between variables were assessed with Pearson's or Spearman's correlation coefficient. A p value equal to or lower than 0.05 was considered statistically significant.
RESULTS
The demographic, clinical and laboratory findings of the controls and patient with microvascular complication are shown in Table 1 . The demographic, clinical and laboratory findings of the controls and patient with microvascular complications.are shown in Table 2 . NPL level of the groups showed no correlation with any parameters including CRP, WBC, and fibrinogen. There was also no correlation between other parameters.
DISCUSSION
The ratio of absolute neutrophil count to absolute lymphocyte count NLR is a crucial marker of systemic inflammation 20 . The present study demonstrated that the mean NLR values were significantly higher in all patients than controls. CAD+DM group has the highest NLR values among the groups. The mean NLR values were significantly higher in CAD+ DM group than DM+nephropathy, DM+neuropathy, and DM+retinopathy. NLR may be considered as a new inflammatory marker for assessment of inflammation in the existence of T2DM (in patients with especially macrovascular complications) with its quick, easily measurable, noninvasive, available and cost-effective property with routine complete blood count analysis.
Several study showed that NLR among subjects with retinopathy was significantly higher than among diabetic patients without retinopathy 9, [21] [22] [23] [24] . Fawwad et al. 21 found that the NLR was 1.14 times higher in diabetic subjects with at least one microvascular complication as compared to diabetic subjects without any complications. Based on the results of their study NLR was considered as an essential and stable marker in diagnosing microvascular diabetic complications. NLR was also significantly higher in patients with nephropathy than in patients without nephropathy. Öztürk et al. 14 reported that increased NLR levels may be associated with microvascular complications of DM and NLR was an independent associate of retinopathy and nephropathy in the elderly population. Contrary to all these results, in our study, there was no significant difference between the DM+nephropathy, DM+neuropathy, and DM+retinopathy. Our results are similar; Ciray et al. 7 found that NLR was not significantly different in patients with and without diabetic retinopathy. Moreover, in contrast to nephropathy, NLR was not an independent associate of diabetic retinopathy. Our results seem more consistent because NLR, CRP, ESR and fibrinogen was not associated with presence of microvascular complication. Consequently larger studies with adequate control of known determinants of NLR are required to better elucidate with relationship between diabetic microvascular complications and NLR 7 .
Increased NLR is associated with severe, extensive and complex CAD (6, 25) . Tanındı et al. 25 showed that NLR is also associated with impaired myocardial perfusion in acute coronary syndrome (ACS), and may be useful for earlier risk stratification and for intensifying the atherosclerosis treatment in higher risk patients. However, in some conditions including traditional risk factors (ie, hypertension, obesity, atherogenic lipoproteins and hyperglycemia) and left ventricular dysfunction or hypertrophy, valvular heart disease, abnormal thyroid function tests and hepatic dysfunction the measurement of NLR can be potentially affected 26 . There were significant differences between the groups regarding the diabetes mellitus, hypertension, hypercholesterolemia and the drug usage (Statin, ACE inhibitor) 27 .
Chittawar et al. 24 showed that patients in higher NLR quartiles had significantly higher diabetes duration, occurrence of CAD and NLR is inexpensive, easy to use, reliable predictor of nephropathy, retinopathy, and CAD in Indian T2DM. Gabbasov et al. 28 evaluated whether the occurrence of restenosis is associated with NLR in patients with T2DM after drug-eluting stent (DES) implantation for stable CAD. They found that elevated NLR may serve as an independent predictor of in-stent restenosis in DES in patients with T2DM and elevated NLR is a characteristic of inflammation. They demonstrate that in patients with T2DM and in-stent restenosis in DES, NLR is elevated even more than in the general population with restenosis. Kim et al. 29 found that both NLR and T2DM were independent prognostic factors significantly associated with significant CAD and that NLR and T2DM added significant incremental value compared with that furnished by conventional cardiovascular risk factors including age, gender, smoking status, HDL cholesterol, and hemoglobin. Also, T2DM patients with high NLR had the greatest prevalence of significant CAD and carotid artery atherosclerosis. Their results suggest an additive impact possibly contributed by T2DM together with high inflammatory state on the development of systemic atherosclerosis. Verdoia et al. 30 represent the largest cohort study thus far to evaluate the impact of diabetes on NLR and its relationship to angiographically proven CAD. They showed that NLR is increased among diabetic patients and is independently associated with the prevalence and severity of CAD in the same population. In current study, the mean NLR values were significantly higher in CAD+DM group than patients with diabetic microvascular complications. But, there was no statistically significant difference in the mean NLR values between CAD group and CAD+DM group. NLR has emerged from among inflammatory parameters as a potential indicator of vascular complications and poorer outcome in patients with diabetes 30 . Accumulating data results and future studies may be helpful in determining in risk stratification for cardiovascular diseases 27 . NLR itself may not give sufficient information to clinicians about the chronic inflammatory disease state of the patient 25 . Results of study demonstrate a possible association of subclinical inflammation with the development of complications in T2DM. NLR are independent indicators for other well-known inflammatory markers as CRP, ESR and fibrinogen, inflammation in development of complications in T2DM. NLR values in prediction of complications in T2DM are a useful parameter. During complications of T2DM, NLR may be useful used as an easily measurable, noninvasive, available and cost-effective parameter with high prognostic accuracy in clinical practice. Detailed studies are particularly required regarding the association of NLR with individual microvascular and macrovascular complications of T2DM. Informed Consent: Informed consent was obtained from the patient who paticipated in this study.
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